40 results on '"Dumont, Jennifer"'
Search Results
2. Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
3. Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study
4. Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization
5. Pulmonary Delivery of an Erythropoietin Fc Fusion Protein in Non-Human Primates through an Immunoglobulin Transport Pathway
6. Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical, humoral and cellular immune responses.
7. Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
8. Efficacy of Efanesoctocog Alfa on Pain in Patients with Hemophilia A: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A
9. Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A
10. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
11. Effects of ozone on stomatal responses to environmental parameters (blue light, red light, CO2 and vapour pressure deficit) in three Populus deltoides × Populus nigra genotypes
12. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
13. Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
14. Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
15. Genome-Wide Association Study and Gene-Based Analysis of Participants With Hemophilia A and Inhibitors in the My Life, Our Future Research Repository
16. Reduction of IgG in Nonhuman Primates by a Peptide Antagonist of the Neonatal Fc Receptor FcRn
17. Prolonged activity of factor IX as a monomeric Fc fusion protein
18. Efficacy of rFVIIIFc for First-Time Immune Tolerance Induction (ITI) Therapy: Final Results from the Global, Prospective VerITI-8 Study
19. Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies
20. Bis(benzyl)polyamine Analogs Inhibit the Growth of Chloroquine-Resistant Human Malaria Parasites (Plasmodium falciparum) in vitro and in Combination with α -difluoromethylornithine Cure Murine Malaria
21. Experience with Accelerometer Physical Activity Tracking in Adults and Adolescents with Hemophilia A: Tool Validation Using Results from the XTEND-1 Efanesoctocog Alfa Phase 3 Trial
22. Experiences with Efanesoctocog Alfa: Exit Interviews with Caregivers of Previously Treated Patients with Hemophilia A from the XTEND-Kids Phase 3 Clinical Trial
23. Ozone affects ascorbate and glutathione biosynthesis as well as amino acid contents in three Euramerican poplar genotypes
24. Increased xerotolerance of Saccharomyces cerevisiae during an osmotic pressure ramp over several generations
25. Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
26. Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure
27. Distinct responses to ozone of stomata in three poplar genotypes
28. Ozone effects on primary metabolism in three poplar genotypes differing in sensitivity
29. Role of stomatal regulation and capacity of foliar detoxification in the estimation of ozone critical level for vegetation
30. Ozone-induced changes in carotenoids and chlorophylls in three Populus clones
31. Detoxification capacity of poplar exposed to ozone: intraspecific variability of three Populus x euramericana genotypes
32. Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates
33. Extravascular Distribution of Conventional and Ehl FIX Products Using In Vivo SPECT Imaging Analysis in Hemophilia B Mice
34. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
35. Dosing Long-Lasting Recombinant Factor VIII Fc Fusion Protein: Experience In The A-LONG Study
36. Factor VIII-Fc Fusion Protein Shows Extended Half-Life and Hemostatic Activity in Hemophilia A Dogs.
37. Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life
38. Flavopiridol Inhibits Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo After Carotid Injury in the Rat
39. Effects of ozone on stomatal responses to environmental parameters (blue light, red light, CO2 and vapour pressure deficit) in three Populus deltoides × Populus nigra genotypes.
40. Reduction of lgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.